Beljaars L - Search Results

1

Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo.

Beljaars L, van der Strate BW, Bakker HI, Reker-Smit C, van Loenen-Weemaes AM, Wiegmans FC, Harmsen MC, Molema G, Meijer DK. Beljaars L, et al. Antiviral Res. 2004 Sep;63(3):197-208. doi: 10.1016/j.antiviral.2004.05.002. Antiviral Res. 2004. PMID: 15451188

2

The antiviral protein human lactoferrin is distributed in the body to cytomegalovirus (CMV) infection-prone cells and tissues.

Beljaars L, Bakker HI, van der Strate BW, Smit C, Duijvestijn AM, Meijer DK, Molema G. Beljaars L, et al. Pharm Res. 2002 Jan;19(1):54-62. doi: 10.1023/a:1013655315969. Pharm Res. 2002. PMID: 11841043

3

Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides.

Berkhout B, van Wamel JL, Beljaars L, Meijer DK, Visser S, Floris R. Berkhout B, et al. Among authors: beljaars l. Antiviral Res. 2002 Aug;55(2):341-55. doi: 10.1016/s0166-3542(02)00069-4. Antiviral Res. 2002. PMID: 12103434

4

Antiviral activities of lactoferrin.

van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK. van der Strate BW, et al. Among authors: beljaars l. Antiviral Res. 2001 Dec;52(3):225-39. doi: 10.1016/s0166-3542(01)00195-4. Antiviral Res. 2001. PMID: 11675140 Review.

5

Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo.

van der Strate BW, Hillebrands JL, Lycklama à Nijeholt SS, Beljaars L, Bruggeman CA, Van Luyn MJ, Rozing J, The TH, Meijer DK, Molema G, Harmsen MC. van der Strate BW, et al. Among authors: beljaars l. J Virol. 2003 Oct;77(20):11274-8. doi: 10.1128/jvi.77.20.11274-11278.2003. J Virol. 2003. PMID: 14512575 Free PMC article.

6

Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis.

Beljaars L, Meijer DK, Poelstra K. Beljaars L, et al. Front Biosci. 2002 May 1;7:e214-22. doi: 10.2741/A917. Front Biosci. 2002. PMID: 11991830 Review.

7

The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins.

Beljaars L, Floris R, Berkhout B, Smit C, Meijer DK, Molema G. Beljaars L, et al. Biochem Pharmacol. 2002 May 1;63(9):1663-73. doi: 10.1016/s0006-2952(02)00912-7. Biochem Pharmacol. 2002. PMID: 12007569

8

Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 following intravenous administration in rats with extensive liver fibrosis.

Rachmawati H, Beljaars L, Reker-Smit C, Van Loenen-Weemaes AM, Hagens WI, Meijer DK, Poelstra K. Rachmawati H, et al. Among authors: beljaars l. Pharm Res. 2004 Nov;21(11):2072-8. doi: 10.1023/b:pham.0000048199.94510.b0. Pharm Res. 2004. PMID: 15587930

9

Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.

Greupink R, Bakker HI, Reker-Smit C, van Loenen-Weemaes AM, Kok RJ, Meijer DK, Beljaars L, Poelstra K. Greupink R, et al. Among authors: beljaars l. J Hepatol. 2005 Nov;43(5):884-92. doi: 10.1016/j.jhep.2005.04.014. Epub 2005 Jun 4. J Hepatol. 2005. PMID: 16083988

10

Prediction of the pharmacokinetics of succinylated human serum albumin in man from in vivo disposition data in animals and in vitro liver slice incubations.

Proost JH, Beljaars L, Olinga P, Swart PJ, Kuipers ME, Reker-Smit C, Groothuis GM, Meijer DK. Proost JH, et al. Among authors: beljaars l. Eur J Pharm Sci. 2006 Feb;27(2-3):123-32. doi: 10.1016/j.ejps.2005.08.014. Epub 2005 Oct 10. Eur J Pharm Sci. 2006. PMID: 16219448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters